308 related articles for article (PubMed ID: 30692694)
1. Precise RNA editing by recruiting endogenous ADARs with antisense oligonucleotides.
Merkle T; Merz S; Reautschnig P; Blaha A; Li Q; Vogel P; Wettengel J; Li JB; Stafforst T
Nat Biotechnol; 2019 Feb; 37(2):133-138. PubMed ID: 30692694
[TBL] [Abstract][Full Text] [Related]
2. New Frontiers for Site-Directed RNA Editing: Harnessing Endogenous ADARs.
Merkle T; Stafforst T
Methods Mol Biol; 2021; 2181():331-349. PubMed ID: 32729089
[TBL] [Abstract][Full Text] [Related]
3. Methods for recruiting endogenous and exogenous ADAR enzymes for site-specific RNA editing.
Xiang Y; Katrekar D; Mali P
Methods; 2022 Sep; 205():158-166. PubMed ID: 35779766
[TBL] [Abstract][Full Text] [Related]
4. Current strategies for Site-Directed RNA Editing using ADARs.
Montiel-Gonzalez MF; Diaz Quiroz JF; Rosenthal JJC
Methods; 2019 Mar; 156():16-24. PubMed ID: 30502398
[TBL] [Abstract][Full Text] [Related]
5. Short-Chain Guide RNA for Site-Directed A-to-I RNA Editing.
Nose K; Hidaka K; Yano T; Tomita Y; Fukuda M
Nucleic Acid Ther; 2021 Feb; 31(1):58-67. PubMed ID: 33170095
[TBL] [Abstract][Full Text] [Related]
6. Programmable RNA editing by recruiting endogenous ADAR using engineered RNAs.
Qu L; Yi Z; Zhu S; Wang C; Cao Z; Zhou Z; Yuan P; Yu Y; Tian F; Liu Z; Bao Y; Zhao Y; Wei W
Nat Biotechnol; 2019 Sep; 37(9):1059-1069. PubMed ID: 31308540
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms and implications of ADAR-mediated RNA editing in cancer.
Wang C; Zou J; Ma X; Wang E; Peng G
Cancer Lett; 2017 Dec; 411():27-34. PubMed ID: 28974449
[TBL] [Abstract][Full Text] [Related]
8. Novel Engineered Programmable Systems for ADAR-Mediated RNA Editing.
Aquino-Jarquin G
Mol Ther Nucleic Acids; 2020 Mar; 19():1065-1072. PubMed ID: 32044725
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive interrogation of the ADAR2 deaminase domain for engineering enhanced RNA editing activity and specificity.
Katrekar D; Xiang Y; Palmer N; Saha A; Meluzzi D; Mali P
Elife; 2022 Jan; 11():. PubMed ID: 35044296
[TBL] [Abstract][Full Text] [Related]
10. Site-directed RNA editing by harnessing ADARs: advances and challenges.
Li M; Yan C; Jiao Y; Xu Y; Bai C; Miao R; Jiang J; Liu J
Funct Integr Genomics; 2022 Dec; 22(6):1089-1103. PubMed ID: 36282404
[TBL] [Abstract][Full Text] [Related]
11. Adenosine-to-inosine RNA editing controls cathepsin S expression in atherosclerosis by enabling HuR-mediated post-transcriptional regulation.
Stellos K; Gatsiou A; Stamatelopoulos K; Perisic Matic L; John D; Lunella FF; Jaé N; Rossbach O; Amrhein C; Sigala F; Boon RA; Fürtig B; Manavski Y; You X; Uchida S; Keller T; Boeckel JN; Franco-Cereceda A; Maegdefessel L; Chen W; Schwalbe H; Bindereif A; Eriksson P; Hedin U; Zeiher AM; Dimmeler S
Nat Med; 2016 Oct; 22(10):1140-1150. PubMed ID: 27595325
[TBL] [Abstract][Full Text] [Related]
12. Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs.
Vogel P; Moschref M; Li Q; Merkle T; Selvasaravanan KD; Li JB; Stafforst T
Nat Methods; 2018 Jul; 15(7):535-538. PubMed ID: 29967493
[TBL] [Abstract][Full Text] [Related]
13. Programmable RNA editing with endogenous ADAR enzymes - a feasible option for the treatment of inherited retinal disease?
Bellingrath JS; McClements ME; Fischer MD; MacLaren RE
Front Mol Neurosci; 2023; 16():1092913. PubMed ID: 37293541
[TBL] [Abstract][Full Text] [Related]
14. Noncoding regions of C. elegans mRNA undergo selective adenosine to inosine deamination and contain a small number of editing sites per transcript.
Wheeler EC; Washburn MC; Major F; Rusch DB; Hundley HA
RNA Biol; 2015; 12(2):162-74. PubMed ID: 25826568
[TBL] [Abstract][Full Text] [Related]
15. ADAR RNA editing below the backbone.
Keegan L; Khan A; Vukic D; O'Connell M
RNA; 2017 Sep; 23(9):1317-1328. PubMed ID: 28559490
[TBL] [Abstract][Full Text] [Related]
16. The RNA editing enzymes ADARs: mechanism of action and human disease.
Tomaselli S; Locatelli F; Gallo A
Cell Tissue Res; 2014 Jun; 356(3):527-32. PubMed ID: 24770896
[TBL] [Abstract][Full Text] [Related]
17. In cancer, A-to-I RNA editing can be the driver, the passenger, or the mechanic.
Ganem NS; Ben-Asher N; Lamm AT
Drug Resist Updat; 2017 May; 32():16-22. PubMed ID: 29145975
[TBL] [Abstract][Full Text] [Related]
18. A high-throughput screen to identify enhancers of ADAR-mediated RNA-editing.
Garncarz W; Tariq A; Handl C; Pusch O; Jantsch MF
RNA Biol; 2013 Feb; 10(2):192-204. PubMed ID: 23353575
[TBL] [Abstract][Full Text] [Related]
19. Base-pairing probability in the microRNA stem region affects the binding and editing specificity of human A-to-I editing enzymes ADAR1-p110 and ADAR2.
Ishiguro S; Galipon J; Ishii R; Suzuki Y; Kondo S; Okada-Hatakeyama M; Tomita M; Ui-Tei K
RNA Biol; 2018; 15(7):976-989. PubMed ID: 29950133
[TBL] [Abstract][Full Text] [Related]
20. RNA editing is induced by type I interferon in esophageal squamous cell carcinoma.
Zhang J; Chen Z; Tang Z; Huang J; Hu X; He J
Tumour Biol; 2017 Jul; 39(7):1010428317708546. PubMed ID: 28714361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
